Drugs

Bile Acid Sequestrants and the Treatment of Type 2 Diabetes Mellitus
pp. 1383-1392(10)
Authors: Staels, Bart; Kuipers, Folkert

Treatment of Premenopausal Women with Early Breast Cancer: Old Challenges and New Opportunities
pp. 1393-1401(9)
Authors: Aebi, Stefan; Pagani, Olivia

Oral Vinorelbine in the Treatment of Non-Small Cell Lung Cancer: Rationale and Implications for Patient Management
pp. 1403-1410(8)
Authors: Gralla, Richard J.; Gatzemeier, Ulrich; Gebbia, Vittorio; Huber, Rudolf; O'Brien, Mary; Puozzo, Christian

Viral Respiratory Tract Infections in Transplant Patients: Epidemiology, Recognition and Management
pp. 1411-1427(17)
Authors: Lee, Ingi; Barton, Todd D.

Hereditary and Acquired Antithrombin Deficiency: Epidemiology, Pathogenesis and Treatment Options
pp. 1429-1440(12)
Authors: Maclean, Peter S.; Tait, R. Campbell

Didanosine Enteric-Coated Capsule: Current Role in Patients with HIV-1 Infection
pp. 1441-1462(22)
Authors: Moreno, Santiago; Hernández, Beatriz; Dronda, Fernando

Medication Noncompliance and its Implications in Transplant Recipients
pp. 1463-1481(19)
Authors: Morrissey, Paul E.; Flynn, Michelle L.; Lin, Sonia

Daptomycin: A Review of its Use in the Management of Complicated Skin and Soft-Tissue Infections and Staphylococcus aureus Bacteraemia
pp. 1483-1512(30)
Authors: Hair, Philip I.; Keam, Susan J.

Human Plasma von Willebrand Factor/Factor VIII Complex (Haemate® P/Humate-P®): In von Willebrand Disease and Haemophilia A
pp. 1513-1519(7)
Authors: Carter, Natalie J.; Scott, Lesley J.

Human Plasma von Willebrand Factor/Factor VIII Complex (Haemate® P/Humate-P®) in von Willebrand Disease and Haemophilia A: A Viewpoint by Eric Berntorp
pp. 1520-1520(1)
Author: Berntorp, Eric